Poster
Lena Knorr
The Sainsbury Laboratory
Norwich, England, United Kingdom
Michelle T. Hulin
Michigan State University
East Lansing, Michigan, United States
Rita Archibong
The Sainsbury Laboratory
Norwich, England, United Kingdom
Danxia He
The Sainsbury Laboratory
Norwich, England, United Kingdom
Wenbo Ma (she/her/hers)
The Sainsbury Laboratory
Norwich, UNITED KINGDOM
Nicotinamide adenine dinucleotide (NAD+) is a universal co-factor and redox carrier involved in various metabolic processes in cells across kingdoms. Recently, it was discovered that Toll/interleukin-1 receptor (TIR) domains of proteins, which are often associated with intracellular immune receptors in plants, function as NAD+ hydrolyzing enzymes and produce specific NAD+-derived products that subsequently activate immune signaling. This discovery links NAD+ metabolism and degradation to immune signaling. Interestingly, pathogens produce host-manipulating effectors that can also hydrolyze NAD+. Our recent analysis on the pangenome of Pseudomonas syringae revealed 13 type III secreted effector families that contain five different NAD+ hydrolase domains. In particular, two effector families employ TIR-like domains to promote disease. Here, we will report on the functional characterizations of the TIR effectors, including their particular NAD+ hydrolysis products during infection and immune suppression activities. The study uncovers novel virulence mechanisms and provides insight into a newly emerged host-pathogen arms race centered on manipulation of immune signaling by NAD+-derived small molecules.